Recent advancements in the diagnosis and treatment of acral melanoma
Acral melanoma (AM) is the most common histologic subtype of melanoma in dark-skinned patients and is associated with a worse prognosis and a high mortality rate, largely due to the inconspicuous nature of early-stage lesions, which can lead to late diagnosis. Because of the overlapping clinical and...
Saved in:
Published in | Journal of Zhejiang University. B. Science Vol. 25; no. 2; pp. 106 - 122 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hangzhou
Zhejiang University Press
01.02.2024
Springer Nature B.V Department of Orthopedics,the First Affiliated Hospital,School of Medicine,Zhejiang University,Hangzhou 310003,China%Department of Orthopaedics,Third Xiangya Hospital,Central South University,Changsha 410013,China%Zhejiang University School of Medicine,Hangzhou 310058,China%Department of Orthopedics,the First Affiliated Hospital,School of Medicine,Zhejiang University,Hangzhou 310003,China Alibaba-Zhejiang University Joint Research Center of Future Digital Healthcare,Zhejiang University,Hangzhou 310058,China |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Acral melanoma (AM) is the most common histologic subtype of melanoma in dark-skinned patients and is associated with a worse prognosis and a high mortality rate, largely due to the inconspicuous nature of early-stage lesions, which can lead to late diagnosis. Because of the overlapping clinical and histopathological features of AM with other forms of cutaneous melanomas, early detection of AM requires a multidisciplinary approach that integrates various diagnostic modalities, including clinical examination, dermoscopy, histopathology, molecular testing, radiological imaging, and blood tests. While surgery is the preferred method of treatment for AM, other therapeutic options may be employed based on the stage and underlying etiology of the disease. Immune checkpoint inhibitors, molecular targeted therapy, radiotherapy, chemotherapy, and oncolytic virotherapy represent promising advanced treatment options for AM. In this review, we provide an overview of the latest advancements in diagnostic and therapeutic methods for AM, highlighting the importance of early detection and the prompt, individualized management of this challenging disease. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ISSN: | 1673-1581 1862-1783 |
DOI: | 10.1631/jzus.B2300221 |